Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62


The renaissance of cholemic nephropathy: A likely underestimated cause of renal dysfunction in liver disease.

Mandorfer M, Hecking M.

Hepatology. 2019 Feb 11. doi: 10.1002/hep.30558. [Epub ahead of print]


Associations between Hemodialysis Facility Practices to Manage Fluid Volume and Intradialytic Hypotension and Patient Outcomes.

Dasgupta I, Thomas GN, Clarke J, Sitch A, Martin J, Bieber B, Hecking M, Karaboyas A, Pisoni R, Port F, Robinson B, Rayner H.

Clin J Am Soc Nephrol. 2019 Feb 5. pii: CJN.08240718. doi: 10.2215/CJN.08240718. [Epub ahead of print]


Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety.

Schwaiger E, Burghart L, Signorini L, Ristl R, Kopecky C, Tura A, Pacini G, Wrba T, Antlanger M, Schmaldienst S, Werzowa J, Säemann MD, Hecking M.

Am J Transplant. 2018 Dec 26. doi: 10.1111/ajt.15223. [Epub ahead of print]


Sex-specific analysis of haemodialysis prevalence, practices and mortality over time: the Austrian Dialysis Registry from 1965 to 2014.

Kainz A, Berner C, Ristl R, Simon A, Stamm T, Zitt E, Kramar R, Antlanger M, Kautzky-Willer A, Schmaldienst S, Schernhammer E, Port FK, Carrero JJ, Jager KJ, Hecking M.

Nephrol Dial Transplant. 2018 Nov 21. doi: 10.1093/ndt/gfy322. [Epub ahead of print]


Anything Goes? High Time for Smart Blood Volume Monitors.

Schneditz D, Kron J, Hecking M.

ASAIO J. 2018 Nov/Dec;64(6):697-700. doi: 10.1097/MAT.0000000000000885. No abstract available.


Greater fluid overload and lower interdialytic weight gain are independently associated with mortality in a large international hemodialysis population.

Hecking M, Moissl U, Genser B, Rayner H, Dasgupta I, Stuard S, Stopper A, Chazot C, Maddux FW, Canaud B, Port FK, Zoccali C, Wabel P.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1832-1842. doi: 10.1093/ndt/gfy083.


A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation.

Werzowa JM, Säemann MD, Mohl A, Bergmann M, Kaltenecker CC, Brozek W, Thomas A, Haidinger M, Antlanger M, Kovarik JJ, Kopecky C, Song PXK, Budde K, Pascual J, Hecking M.

PLoS One. 2018 Mar 8;13(3):e0193569. doi: 10.1371/journal.pone.0193569. eCollection 2018.


EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation.

Linder M, Hecking M, Glitzner E, Zwerina K, Holcmann M, Bakiri L, Ruocco MG, Tuckermann J, Schett G, Wagner EF, Sibilia M.

Cell Death Differ. 2018 Jun;25(6):1094-1106. doi: 10.1038/s41418-017-0054-7. Epub 2018 Feb 14.


Correspondence regarding the impact of kidney transplantation on insulin sensitivity.

Bergfeld L, Werzowa J, Säemann M, Hecking M.

Transpl Int. 2018 Apr;31(4):456-457. doi: 10.1111/tri.13124. Epub 2018 Feb 21. No abstract available.


Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease.

Carrero JJ, Hecking M, Chesnaye NC, Jager KJ.

Nat Rev Nephrol. 2018 Mar;14(3):151-164. doi: 10.1038/nrneph.2017.181. Epub 2018 Jan 22. Review.


The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck® parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment.

Knafl D, Müller M, Pajenda S, Genc Z, Hecking M, Wagner L.

PLoS One. 2017 Nov 16;12(11):e0188316. doi: 10.1371/journal.pone.0188316. eCollection 2017.


Chronic kidney disease, mineral bone disease and future risk of peripheral artery disease: Do associations rule?

Hecking M, Höbaus C, Schernthaner GH.

Atherosclerosis. 2017 Dec;267:153-155. doi: 10.1016/j.atherosclerosis.2017.10.023. Epub 2017 Oct 23. No abstract available.


Feedback Control in Hemodialysis-Much Ado about Nothing?

Hecking M, Schneditz D.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1730-1732. doi: 10.2215/CJN.09770917. Epub 2017 Oct 10. No abstract available.


Intravenous Fluid Challenge Decreases Intracellular Volume: A Bioimpedance Spectroscopy-Based Crossover Study in Healthy Volunteers.

Ernstbrunner M, Kabon B, Zotti O, Zeitlinger M, Berner C, Hinterholzer G, Säemann M, Frommlet F, Fleischmann E, Hecking M.

Sci Rep. 2017 Aug 29;7(1):9644. doi: 10.1038/s41598-017-09433-5.


Blood volume-monitored regulation of ultrafiltration to decrease the dry weight in fluid-overloaded hemodialysis patients: a randomized controlled trial.

Antlanger M, Josten P, Kammer M, Exner I, Lorenz-Turnheim K, Eigner M, Paul G, Klauser-Braun R, Sunder-Plassmann G, Säemann MD, Hecking M.

BMC Nephrol. 2017 Jul 17;18(1):238. doi: 10.1186/s12882-017-0639-x.


Regional Differences in the Associations Between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the Dialysis Outcomes and Practice Patterns Study.

Hecking M, Wong MMY, Port FK, Robinson BM, McCullough KP.

Am J Kidney Dis. 2017 Sep;70(3):450-451. doi: 10.1053/j.ajkd.2017.03.024. Epub 2017 May 24. No abstract available.


Chronic Kidney Disease, Gender, and Access to Care: A Global Perspective.

Carrero JJ, Hecking M, Ulasi I, Sola L, Thomas B.

Semin Nephrol. 2017 May;37(3):296-308. doi: 10.1016/j.semnephrol.2017.02.009. Review.


Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis.

Antlanger M, Aschauer S, Kopecky C, Hecking M, Kovarik JJ, Werzowa J, Mascherbauer J, Genser B, Säemann MD, Bonderman D.

Kidney Blood Press Res. 2017;42(1):165-176. doi: 10.1159/000473868. Epub 2017 Apr 11.


Fluid status and outcome in patients with heart failure and preserved ejection fraction.

Koell B, Zotter-Tufaro C, Duca F, Kammerlander AA, Aschauer S, Dalos D, Antlanger M, Hecking M, Säemann M, Mascherbauer J, Bonderman D.

Int J Cardiol. 2017 Mar 1;230:476-481. doi: 10.1016/j.ijcard.2016.12.080. Epub 2016 Dec 21.


Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS).

Wong MM, McCullough KP, Bieber BA, Bommer J, Hecking M, Levin NW, McClellan WM, Pisoni RL, Saran R, Tentori F, Tomo T, Port FK, Robinson BM.

Am J Kidney Dis. 2017 Mar;69(3):367-379. doi: 10.1053/j.ajkd.2016.08.030. Epub 2016 Nov 17.


Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients.

Kovarik JJ, Kopecky C, Antlanger M, Domenig O, Kaltenecker CC, Werzowa J, Hecking M, Mahr S, Grömmer M, Wallner C, Aumayr K, Kain R, Zuckermann A, Poglitsch M, Säemann MD.

J Heart Lung Transplant. 2017 Mar;36(3):355-365. doi: 10.1016/j.healun.2016.08.022. Epub 2016 Sep 13.


Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis.

Cobo G, Hecking M, Port FK, Exner I, Lindholm B, Stenvinkel P, Carrero JJ.

Clin Sci (Lond). 2016 Jul 1;130(14):1147-63. doi: 10.1042/CS20160047. Review.


Molecular regulation of the renin-angiotensin system in haemodialysis patients.

Kovarik JJ, Antlanger M, Domenig O, Kaltenecker CC, Hecking M, Haidinger M, Werzowa J, Kopecky C, Säemann MD.

Nephrol Dial Transplant. 2016 May;31(5):851. doi: 10.1093/ndt/gfw071. Epub 2016 Mar 23. No abstract available.


Assessment of beta-cell function and insulin secretion in subjects that underwent renal transplantation.

Tura A, Hecking M, Wolzt M, Saemann MD, Pacini G.

Conf Proc IEEE Eng Med Biol Soc. 2015;2015:2371-4. doi: 10.1109/EMBC.2015.7318870.


Prophylactic CMV therapy does not improve three-yr patient and graft survival compared to preemptive therapy.

Werzowa J, Schwaiger B, Hecking M, Strassl R, Schmaldienst S, Böhmig GA, Genser B, Säemann MD.

Clin Transplant. 2015 Dec;29(12):1230-8. doi: 10.1111/ctr.12657. Epub 2015 Nov 25.


Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus.

Werzowa J, Pacini G, Hecking M, Fidler C, Haidinger M, Brath H, Thomas A, Säemann MD, Tura A.

J Diabetes Complications. 2015 Nov-Dec;29(8):1211-6. doi: 10.1016/j.jdiacomp.2015.07.014. Epub 2015 Jul 17.


The diagnosis of posttransplantation diabetes mellitus: meeting the challenges.

Werzowa J, Hecking M, Haidinger M, Döller D, Sharif A, Tura A, Säemann MD.

Curr Diab Rep. 2015 May;15(5):27. doi: 10.1007/s11892-015-0601-x. Review.


What are the Consequences of Volume Expansion in Chronic Dialysis Patients?: Defining and Measuring Fluid Overload in Hemodialysis Patients.

Hecking M, Rayner H, Wabel P.

Semin Dial. 2015 May-Jun;28(3):242-7. doi: 10.1111/sdi.12355. Epub 2015 Mar 1. No abstract available.


More evidence needed before lower dialysate sodium concentrations can be recommended.

Hecking M, Rayner H, Port FK.

Am J Kidney Dis. 2015 Mar;65(3):519-20. doi: 10.1053/j.ajkd.2014.10.026. No abstract available.


Antidiabetic therapy in post kidney transplantation diabetes mellitus.

Werzowa J, Säemann M, Haidinger M, Krebs M, Hecking M.

Transplant Rev (Orlando). 2015 Jul;29(3):145-53. doi: 10.1016/j.trre.2015.01.001. Epub 2015 Jan 14. Review.


Bioimpedance spectroscopy for assessment of volume status in patients before and after general anaesthesia.

Ernstbrunner M, Kostner L, Kimberger O, Wabel P, Säemann M, Markstaller K, Fleischmann E, Kabon B, Hecking M.

PLoS One. 2014 Oct 31;9(10):e111139. doi: 10.1371/journal.pone.0111139. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0117956.


Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Hecking M, Bieber BA, Ethier J, Kautzky-Willer A, Sunder-Plassmann G, Säemann MD, Ramirez SP, Gillespie BW, Pisoni RL, Robinson BM, Port FK.

PLoS Med. 2014 Oct 28;11(10):e1001750. doi: 10.1371/journal.pmed.1001750. eCollection 2014 Oct.


Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions.

Sharif A, Hecking M, de Vries AP, Porrini E, Hornum M, Rasoul-Rockenschaub S, Berlakovich G, Krebs M, Kautzky-Willer A, Schernthaner G, Marchetti P, Pacini G, Ojo A, Takahara S, Larsen JL, Budde K, Eller K, Pascual J, Jardine A, Bakker SJ, Valderhaug TG, Jenssen TG, Cohney S, Säemann MD.

Am J Transplant. 2014 Sep;14(9):1992-2000. doi: 10.1111/ajt.12850. Epub 2014 Aug 6.


Molecular regulation of the renin-angiotensin system in haemodialysis patients.

Kovarik JJ, Antlanger M, Domenig O, Kaltenecker CC, Hecking M, Haidinger M, Werzowa J, Kopecky C, Säemann MD.

Nephrol Dial Transplant. 2015 Jan;30(1):115-23. doi: 10.1093/ndt/gfu265. Epub 2014 Aug 8. Erratum in: Nephrol Dial Transplant. 2016 May;31(5):851.


Restoration of renal function does not correct impairment of uremic HDL properties.

Kopecky C, Haidinger M, Birner-Grünberger R, Darnhofer B, Kaltenecker CC, Marsche G, Holzer M, Weichhart T, Antlanger M, Kovarik JJ, Werzowa J, Hecking M, Säemann MD.

J Am Soc Nephrol. 2015 Mar;26(3):565-75. doi: 10.1681/ASN.2013111219. Epub 2014 Jul 28.


Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.

Bielesz BO, Hecking M, Plischke M, Cejka D, Kieweg H, Haas M, Marculescu R, Hörl WH, Bieglmayer C, Sunder-Plassmann G.

Clin Biochem. 2014 Sep;47(13-14):1316-9. doi: 10.1016/j.clinbiochem.2014.06.009. Epub 2014 Jun 21.


Dialysate sodium prescription and blood pressure in hemodialysis patients.

Hecking M, Karaboyas A, Rayner H, Saran R, Sen A, Inaba M, Bommer J, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Port FK.

Am J Hypertens. 2014 Sep;27(9):1160-9. doi: 10.1093/ajh/hpu040. Epub 2014 Mar 20.


Current evidence argues against lowering the dialysate sodium.

Port F, Hecking M, Karaboyas A, Pisoni R, Robinson B.

Nephrol News Issues. 2013 Dec;27(13):18-21. No abstract available.


Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Rayner HC, Zepel L, Fuller DS, Morgenstern H, Karaboyas A, Culleton BF, Mapes DL, Lopes AA, Gillespie BW, Hasegawa T, Saran R, Tentori F, Hecking M, Pisoni RL, Robinson BM.

Am J Kidney Dis. 2014 Jul;64(1):86-94. doi: 10.1053/j.ajkd.2014.01.014. Epub 2014 Feb 14.


Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status.

Antlanger M, Hecking M, Haidinger M, Werzowa J, Kovarik JJ, Paul G, Eigner M, Bonderman D, Hörl WH, Säemann MD.

BMC Nephrol. 2013 Dec 2;14:266. doi: 10.1186/1471-2369-14-266.


Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial.

Haidinger M, Werzowa J, Hecking M, Antlanger M, Stemer G, Pleiner J, Kopecky C, Kovarik JJ, Döller D, Pacini G, Säemann MD.

Am J Transplant. 2014 Jan;14(1):115-23. doi: 10.1111/ajt.12518. Epub 2013 Nov 26.


Comment on: Chakkera et al. Can new-onset diabetes after kidney transplant be prevented? Diabetes Care 2013;36:1406-1412.

Hecking M, Sharif A, Port FK, Säemann MD.

Diabetes Care. 2013 Oct;36(10):e182. doi: 10.2337/dc13-1277. No abstract available.


Significance of interdialytic weight gain versus chronic volume overload: consensus opinion.

Hecking M, Karaboyas A, Antlanger M, Saran R, Wizemann V, Chazot C, Rayner H, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Moissl U, Kotanko P, Levin NW, Säemann MD, Kalantar-Zadeh K, Port FK, Wabel P.

Am J Nephrol. 2013;38(1):78-90. doi: 10.1159/000353104. Epub 2013 Jul 6.


Glucose metabolism after renal transplantation.

Hecking M, Kainz A, Werzowa J, Haidinger M, Döller D, Tura A, Karaboyas A, Hörl WH, Wolzt M, Sharif A, Roden M, Moro E, Pacini G, Port FK, Säemann MD.

Diabetes Care. 2013 Sep;36(9):2763-71. doi: 10.2337/dc12-2441. Epub 2013 May 8.


Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature.

Haidinger M, Werzowa J, Kain R, Antlanger M, Hecking M, Pfaffenberger S, Mascherbauer J, Gremmel T, Gilbertson JA, Rowczenio D, Weichhart T, Kopecky C, Hörl WH, Hawkins PN, Säemann MD.

Amyloid. 2013 Jun;20(2):72-9. doi: 10.3109/13506129.2013.781998. Epub 2013 Apr 3.


Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial.

Werzowa J, Hecking M, Haidinger M, Lechner F, Döller D, Pacini G, Stemer G, Pleiner J, Frantal S, Säemann MD.

Transplantation. 2013 Feb 15;95(3):456-62. doi: 10.1097/TP.0b013e318276a20e.


Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

Hecking M, Werzowa J, Haidinger M, Hörl WH, Pascual J, Budde K, Luan FL, Ojo A, de Vries AP, Porrini E, Pacini G, Port FK, Sharif A, Säemann MD; European-New-Onset Diabetes After Transplantation Working Group.

Nephrol Dial Transplant. 2013 Mar;28(3):550-66. doi: 10.1093/ndt/gfs583. Epub 2013 Jan 17.


Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patients.

Hecking M, Kainz A, Bielesz B, Plischke M, Beilhack G, Hörl WH, Sunder-Plassmann G, Bieglmayer C.

Clin Biochem. 2012 Dec;45(18):1645-51. doi: 10.1016/j.clinbiochem.2012.08.006. Epub 2012 Aug 11.


Clinical trials for treatment of NODAT: time to collaborate.

Sharif A, de Vries AP, Porrini E, Hecking M, Saemann M; European–New-Onset Diabetes After Transplantation Working Group.

Transplantation. 2012 Aug 27;94(4):e23-4; author reply e24-5. No abstract available.


Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial.

Hecking M, Antlanger M, Winnicki W, Reiter T, Werzowa J, Haidinger M, Weichhart T, Polaschegg HD, Josten P, Exner I, Lorenz-Turnheim K, Eigner M, Paul G, Klauser-Braun R, Hörl WH, Sunder-Plassmann G, Säemann MD.

Trials. 2012 Jun 8;13:79. doi: 10.1186/1745-6215-13-79.

Supplemental Content

Loading ...
Support Center